A Clinical Trial to Compare Lasotronix Alone or in Combination With CPP-ACP to Treat DH
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age25-65
SponsorDow University of Health Sciences
About this trial
Dentin hypersensitivity (DH) is defined as sharp pain of a shorter duration arise from exposed dentin in response to several chemicals and thermal or tactile stimuli that cannot be ascribed to other dental defects". DH has a prevalence rate ranging from 1.3% to 92.1%, commonly affecting old ages. The use of laser has opened new dimensions in the treatment of DH. To the author's knowledge, not much research work has been conducted using LASOTRONIX as a treatment modality with CPP-ACP. Therefore, this research aims to determine the effectiveness of Casein phospho peptide paste (CPP-ACP) used alone or combined with a diode laser (LASOTRONIX).
Eligibility criteria
This trial accepts healthy volunteersQualifiers
Patients of either gender, with ages between 25-65 years
should have at least more than one hypersensitive and vital tooth without any carious lesion or defective restoration
Disqualifiers
History of desensitizing therapy on the affected tooth/teeth in last six months (use of desensitizing toothpaste)
use of antibiotics /analgesic/anti-inflammatory drugs
history of smoking
pregnancy
Trial design
Design model
Parallel
Treatments tested in this trial
Active comparator
Other interventionCPP-ACP paste will be applied on exposed area
Experimental group
DeviceLasotronix will be applied following its protocol
Combination of laser and paste
Combination productThis group will receive the combination of above two treatments
Control group
Behavioralthis will be a control group
Treatment groups
120 Participants
are divided into 4 treatment groupsGroup A: Active ComparatorActive comparator 1 intervention
Group B: ExperimentalExperimental treatment 1 intervention
Group C: CombinationOther 1 intervention
Group D: ControlOther 1 intervention
Trial outcomes
Primary outcomes
1
treatment of dentin hypersensitivity
VAS Visual analogue scale will be used to determine the efficacy of different treatment methods.
Time frame
0-3 mothsSponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov